In a phase II study utilizing BV in adults with relapsed or refractory (R/R) ALCL, 86% of patients had an objective response, and 66% achieved a complete response with ALK‐positive and ALK‐negative disease having similar response rates.83, 84. Here, ALK is linked to anaplastic large cell lymphoma.